🔎 Trials Near Me

Dachaigh › Carcinoma Epithelial Ovarian › Massachusetts

Sgrùdaidhean clionaigeach Carcinoma Epithelial Ovarian ann an Massachusetts

Tha 9 sgrùdaidhean airson Carcinoma Epithelial Ovarian a’ lorg phàirtichean aig làraichean ann an Massachusetts.

Bailtean ann an Massachusetts

Teacsa sgrùdaidh oifigeil (Beurla)

A Study of Isoquercetin in People With Ovarian Cancer

  • Beth Israel Deaconess Medical Center (Data Collection Only), Boston
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 15 Sult 2026 · NCT07303894

AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platinum-resistant Ovarian Cancer

  • Research Site, Burlington
  • Research Site, Worcester
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Banairean · Air ùrachadh 21 Iuch 2026 · NCT07218809

Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)

  • Massachusetts General Hospital, Boston
  • Dana-Farber Cancer Institute, Boston
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Banairean · Air ùrachadh 2 Iuch 2026 · NCT06819007

A Study of Azenosertib (ZN-c3) in Patients With Ovarian Cancer

  • Site 0104, Boston
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Banairean · Air ùrachadh 7 Gibl 2026 · NCT04516447

A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies

  • Massachusetts General Hospital, Boston
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 27 Màrt 2026 · NCT06395519

CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.

  • Massachusetts General Hospital, Boston
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Banairean · Air ùrachadh 23 Dùbh 2025 · NCT06690775

Developing a Test of Uterine Lavage for the Detection of Ovarian Cancer

  • Massachusetts General Hospital, Boston
A’ fastadhSgrùdadh amharc
Aoisean 30 agus nas sine · Banairean · Air ùrachadh 16 Sult 2025 · NCT04794322

Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors

  • Dana Farber/Partners Cancer Care Inc, Boston
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 15 Lùna 2025 · NCT04429542

Bho ClinicalTrials.gov, dàta air a thogail 5 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.